InsiderClue
Insiders · Profile

SILVERSTEIN JONATHAN

Director at Arcutis Biotherapeutics · Director at GLAUKOS · Director at Adicet Bio. Filing since 3 Aug 2016. CIK 0001171005

ARQT Arcutis Biotherapeutics, Inc. Director · 2 trades GKOS GLAUKOS Corp Director · 17 trades ACET Adicet Bio, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
ARQT Arcutis Biotherapeutics, Inc.
2 Oct 2020
Director
Bought
496,000
$12.40M
13.2%
ARQT Arcutis Biotherapeutics, Inc.
3 Feb 2020
Director
Bought
558,888
$9.50M
opened
GKOS GLAUKOS Corp
6 Mar 2018
Director
Sold, plan not stated
161,321
$4.95M
100%
GKOS GLAUKOS Corp
5 Mar 2018
Director
Sold, plan not stated
210,596
$6.83M
99.3%
GKOS GLAUKOS Corp
2 Mar 2018
Director
Sold, plan not stated
464,583
$15.00M
99.2%
ACET Adicet Bio, Inc.
30 Jan 2018
Director
Bought
533,333
$8.00M
12.4%
GKOS GLAUKOS Corp
5 Sep 2017
Director
Sold, plan not stated
425,200
$16.62M
98.2%
GKOS GLAUKOS Corp
1 Sep 2017
Director
Sold, plan not stated
110,078
$4.15M
90.2%
GKOS GLAUKOS Corp
31 Aug 2017
Director
Sold, plan not stated
44,922
$1.70M
77.6%
GKOS GLAUKOS Corp
17 Aug 2017
Director
Sold, plan not stated
226,920
$8.59M
94.4%
GKOS GLAUKOS Corp
16 Aug 2017
Director
Sold, plan not stated
65,580
$2.49M
80.9%
GKOS GLAUKOS Corp
15 Aug 2017
Director
Sold, plan not stated
32,500
$1.24M
66.8%
GKOS GLAUKOS Corp
14 Mar 2017
Director
Sold, plan not stated
74,100
$3.30M
81.8%
GKOS GLAUKOS Corp
13 Mar 2017
Director
Sold, plan not stated
211,410
$9.58M
92.5%
GKOS GLAUKOS Corp
10 Mar 2017
Director
Sold, plan not stated
97,028
$4.46M
83.5%
GKOS GLAUKOS Corp
3 Mar 2017
Director
Sold, plan not stated
55,772
$2.62M
73.6%
GKOS GLAUKOS Corp
12 Aug 2016
Director
Sold, plan not stated
14,100
$475.45K
40.7%
GKOS GLAUKOS Corp
11 Aug 2016
Director
Sold, plan not stated
160,900
$5.41M
88.6%
GKOS GLAUKOS Corp
10 Aug 2016
Director
Sold, plan not stated
117,938
$3.98M
84.1%
GKOS GLAUKOS Corp
3 Aug 2016
Director
Sold, plan not stated
425,000
$13.00M
94.8%
20 decisions on file.